HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bolus administration of intravenous glucose in the treatment of hyperkalemia: a randomized controlled trial.

AbstractBACKGROUND:
Hyperkalemia is a common medical emergency that may result in serious cardiac arrhythmias. Standard therapy with insulin plus glucose reliably lowers the serum potassium concentration ([K(+)]) but carries the risk of hypoglycemia. This study examined whether an intravenous glucose-only bolus lowers serum [K(+)] in stable, nondiabetic, hyperkalemic patients and compared this intervention with insulin-plus-glucose therapy.
METHODS:
A randomized, crossover study was conducted in 10 chronic hemodialysis patients who were prone to hyperkalemia. Administration of 10 units of insulin with 100 ml of 50% glucose (50 g) was compared with the administration of 100 ml of 50% glucose only. Serum [K(+)] was measured up to 60 min. Patients were monitored for hypoglycemia and EKG changes.
RESULTS:
Baseline serum [K(+)] was 6.01 ± 0.87 and 6.23 ± 1.20 mmol/l in the insulin and glucose-only groups, respectively (p = 0.45). At 60 min, the glucose-only group had a fall in [K(+)] of 0.50 ± 0.31 mmol/l (p < 0.001). In the insulin group, there was a fall of 0.83 ± 0.53 mmol/l at 60 min (p < 0.001) and a lower serum [K(+)] at that time compared to the glucose-only group (5.18 ± 0.76 vs. 5.73 ± 1.12 mmol/l, respectively; p = 0.01). In the glucose-only group, the glucose area under the curve (AUC) was greater and the insulin AUC was smaller. Two patients in the insulin group developed hypoglycemia.
CONCLUSION:
Infusion of a glucose-only bolus caused a clinically significant decrease in serum [K(+)] without any episodes of hypoglycemia.
AuthorsMogamat-Yazied Chothia, Mitchell L Halperin, Megan A Rensburg, Mogamat Shafick Hassan, Mogamat Razeen Davids
JournalNephron. Physiology (Nephron Physiol) Vol. 126 Issue 1 Pg. 1-8 ( 2014) ISSN: 1660-2137 [Electronic] Switzerland
PMID24576893 (Publication Type: Journal Article, Randomized Controlled Trial)
Copyright2014 S. Karger AG, Basel.
Chemical References
  • Insulin
  • Glucose
  • Potassium
Topics
  • Administration, Intravenous
  • Adult
  • Cross-Over Studies
  • Double-Blind Method
  • Drug Therapy, Combination
  • Female
  • Glucose (administration & dosage, therapeutic use)
  • Humans
  • Hyperkalemia (complications, drug therapy)
  • Insulin (administration & dosage, therapeutic use)
  • Kidney Failure, Chronic (complications, therapy)
  • Male
  • Potassium (blood)
  • Renal Dialysis (methods)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: